Blog Posts in Dangerous Drugs

All Posts
  • Florida Man Alleges OTC Blood Pressure Medication Contained Carcinogen
    Florida Man Alleges OTC Blood Pressure Medication Contained Carcinogen

    Florida Resident Sues Prinston Pharmaceutical for Presence of Carcinogens in Over-the-Counter Blood Pressure Medication On October 25, 2018, Florida resident Ron Molinaro filed a complaint against ...

    Read More
  • NDMA-Contaminated Valsartan Puts Consumers at Risk for Cancer
    NDMA-Contaminated Valsartan Puts Consumers at Risk for Cancer

    Batches of Valsartan Found to Contain Known Carcinogen, N-nitrosodimethylamine (NDMA) N-nitrosodimethylamine (NDMA) is a naturally occurring substance that is yellow, odorless, and toxic. It is a ...

    Read More
  • Johnson & Johnson Seeks to Expand Xarelto Use Despite Lawsuit Losses
    Johnson & Johnson Seeks to Expand Xarelto Use Despite Lawsuit Losses

    J & J Attempting to Expand the Use of Xarelto Despite Lawsuits On the heels of a recent $27.8M jury verdict, and with lawsuits rising in number, Johnson & Johnson is attempting to obtain a label ...

    Read More
  • Potentially Dangerous Side Effects of Leukemia Drug Tasigna
    Potentially Dangerous Side Effects of Leukemia Drug Tasigna

    Novartis Leukemia Drug Under Fire Yet another potentially dangerous drug, Tasigna, manufactured by Novartis, has come under fire. Tasigna, used in the treatment of leukemia, may have some very serious ...

    Read More
  • Farmworkers Want Chlorpyrifos Pesticide Banned After EPA Refuses
    Farmworkers Want Chlorpyrifos Pesticide Banned After EPA Refuses

    Environmentalists and farmworkers in California are pushing for the ban of a commonly used conventional insecticide. Back in 2015, the Environmental Protection Agency (EPA) under President Obama, ...

    Read More
  • Does Actemra Have the Same Risks as Vioxx?
    Does Actemra Have the Same Risks as Vioxx?

    Actemra is an injectable drug used for aduIts who suffer from rheumatoid arthritis, and the resulting chronic inflammation. Actemra, granted FDA approval in 2010, and manufactured by Roche and its ...

    Read More